Castle Biosciences, Inc.CSTLNASDAQ
LOADING
|||
Gross Profit Over Time
Trending higher, above historical average, strong compound growth.
Left:
||||
Revenue minus cost of goods sold
Latest
$271.86M
↑ 189% above average
Average (7y)
$94.23M
Historical baseline
Range
High:$271.86M
Low:$8.83M
CAGR
+63.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $271.86M | +55.5% |
| 2023 | $174.81M | +66.4% |
| 2022 | $105.03M | +34.2% |
| 2021 | $78.26M | +47.8% |
| 2020 | $52.96M | +18.9% |
| 2019 | $44.55M | +154.8% |
| 2018 | $17.49M | +98.0% |
| 2017 | $8.83M | - |